Latest NewsSep 25, 2025HiFiBiO Therapeutics to Present Updated Phase 1 Clinical Data of Two Immuno-Oncology Programs at the 2025 Annual Meeting of the European Society for Medical Oncology (ESMO) All Filter By: Year20252024202320222021202020192018201720162015Mar 19, 2021HiFiBiO and Gustave Roussy Researchers Demonstrate the Contribution of Galectin-9 (Gal-9) in Tumor Immune EscapeLioness Magazine Interview | Interview | Mar 11, 2021HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by Lioness MagazinePharmaBoardRoom Article | Article | Mar 8, 2021HiFiBiO Therapeutics CEO Liang Schweizer Interviewed by PharmaBoardRoom and Genialis PodcastOct 27, 2020HiFiBiO Therapeutics CEO Liang Schweizer Named one of the World’s Top Female FoundersOct 26, 2020HiFiBiO Therapeutics Completes First Cohort of a Phase I Study of its SARS-CoV-2 Neutralizing Antibody for the Treatment and Prevention of COVID-19< 1 … 8 9 10 11 12 … 18 >
